Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Arterial Occlusive Diseases D001157 12 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Cat Diseases D002371 12 associated lipids
Death, Sudden D003645 12 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Polycythemia Vera D011087 13 associated lipids
Eye Burns D005126 13 associated lipids
Acidosis D000138 13 associated lipids
Airway Obstruction D000402 13 associated lipids
Pain, Postoperative D010149 13 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Cerebral Hemorrhage D002543 13 associated lipids
Uveitis D014605 14 associated lipids
Angina, Unstable D000789 14 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Neutropenia D009503 15 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Carotid Stenosis D016893 15 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Alcoholic Intoxication D000435 15 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Blister D001768 16 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Celiac Disease D002446 16 associated lipids
Vascular Diseases D014652 16 associated lipids
Choline Deficiency D002796 16 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Ulcer D014456 16 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Albuminuria D000419 18 associated lipids
Bronchial Spasm D001986 18 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Nephritis D009393 19 associated lipids
Cough D003371 19 associated lipids
Pregnancy Complications D011248 19 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Peptic Ulcer D010437 19 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Wounds and Injuries D014947 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Simmons PM et al. The release of leukotriene B4 during experimental inflammation. 1983 Biochem. Pharmacol. pmid:6305369
Pestel S et al. Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate. 2003 Biochem. Pharmacol. pmid:12906929
Llopis J et al. Eicosanoids released following inhibition of the endoplasmic reticulum Ca2+ pump stimulate Ca2+ efflux in the perfused rat liver. 1993 Biochem. Pharmacol. pmid:8390834
Takayasu-Okishio M et al. Endothelin-1 and platelet activating factor stimulate thromboxane A2 biosynthesis in rat vascular smooth muscle cells. 1990 Biochem. Pharmacol. pmid:2260994
Ko FN et al. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr. 1993 Biochem. Pharmacol. pmid:8216367
Krämer HJ et al. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. 1996 Biochem. Pharmacol. pmid:8937428
Satoh K et al. Effects of sulfonylurea agents on platelet arachidonic acid metabolism; study on platelet homogenates. 1994 Biochem. Pharmacol. pmid:8093094
Best LC et al. Strontium ions induce production of thromboxane B2 and secretion of 5-hydroxytryptamine in washed human platelets. 1981 Biochem. Pharmacol. pmid:6268118
Vanderhoek JY et al. Inhibitory potencies of fish oil hydroxy fatty acids on cellular lipoxygenases and platelet aggregation. 1991 Biochem. Pharmacol. pmid:1831021
Cerletti C et al. Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors. 1986 Biochem. Pharmacol. pmid:3083818
Krishnamurthi S et al. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. 1984 Biochem. Pharmacol. pmid:6091666
Klosterhalfen B et al. Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia. 1996 Biochem. Pharmacol. pmid:8937427
Chang WC et al. Inhibition of thromboxane B2 and 6-ketoprostaglandin F1 alpha formation by anti-inflammatory drugs in carrageenin-induced granuloma. 1978 Biochem. Pharmacol. pmid:619892
Kusner EJ et al. Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro. 1989 Biochem. Pharmacol. pmid:2557041
Oishi K and Yamaguchi M Regulatory effect of arachidonic acid on the calcium transport system in rat liver nuclei. 1993 Biochem. Pharmacol. pmid:8385946
Tanizawa H and Tai HH Synergism between chemotactic peptide and platelet-activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils. 1989 Biochem. Pharmacol. pmid:2547385
Covatto RH and Niewiarowski S Platelet thromboxane A2/prostaglandin H2 receptors in human volunteers on low doses of aspirin. 1990 Biochem. Pharmacol. pmid:2145839
Faili A et al. Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha. 1993 Biochem. Pharmacol. pmid:8388209
Huang TF et al. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. 1991 Biochem. Pharmacol. pmid:1888330
Erman A et al. The role of eicosanoids in cyclosporine nephrotoxicity in the rat. 1989 Biochem. Pharmacol. pmid:2735953
Grieve EM et al. The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition. 1993 Biochem. Pharmacol. pmid:8466554
Wald M et al. Role of thromboxanes in alterations of the diabetic beta-adrenergic system. 1989 Biochem. Pharmacol. pmid:2554922
Salmon JA et al. Benoxaprofen does not inhibit formation of leukotriene B4 in a model of acute inflammation. 1984 Biochem. Pharmacol. pmid:6089840
Gresele P et al. L-652,343, a novel dual cyclo/lipoxygenase inhibitor, inhibits LTB4-production by stimulated human polymorphonuclear cells but not by stimulated human whole blood. 1987 Biochem. Pharmacol. pmid:2823826
Fischer S et al. In vivo and in vitro effects of nafazatrom (Bay g 6575), an antithrombotic compound, on arachidonic acid metabolism in platelets and vascular tissue. 1983 Biochem. Pharmacol. pmid:6688182
De La Cruz JP et al. Effects of S-adenosyl-L-methionine on platelet thromboxane and vascular prostacyclin. 1997 Biochem. Pharmacol. pmid:9264331
Maynard PM et al. Effect of glutathione depletion on tissue and plasma prostacyclin and thromboxane in rats. 1992 Biochem. Pharmacol. pmid:1554377
de Gaetano G et al. Low dose aspirin does not prevent fibrinolytic response to venous occlusion. 1986 Biochem. Pharmacol. pmid:3755907
Weisman SM et al. Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction. 1988 Biochem. Pharmacol. pmid:2840083
Yuk DY et al. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative. 2000 Biochem. Pharmacol. pmid:10974210
Lloret S and Moreno JJ In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins. 1992 Biochem. Pharmacol. pmid:1417964
Chou TC et al. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process. 1999 Biochem. Pharmacol. pmid:10535758
Koehler L et al. Glucocorticoid-induced reduction of prostanoid synthesis in TPA-differentiated U937 cells is mainly due to a reduced cyclooxygenase activity. 1990 Biochem. Pharmacol. pmid:2119586
Kerry R et al. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility. 1984 Biochem. Pharmacol. pmid:6147145
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Shih CY and Chou TC The antiplatelet activity of magnolol is mediated by PPAR-β/γ. 2012 Biochem. Pharmacol. pmid:22750553
Williamson EM et al. Studies on the mechanism of action of 12-deoxyphorbolphenylacetate, a potent platelet aggregating tigliane ester. 1981 Biochem. Pharmacol. pmid:6794576
Lorenz RL et al. Effects on prostanoid formation and pharmacokinetics of dazmegrel (UK-38,485), a novel thromboxane synthase inhibitor, in man. 1986 Biochem. Pharmacol. pmid:3513767
Sumner H et al. Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components. 1992 Biochem. Pharmacol. pmid:1319159
Suntres ZE and Shek PN Prophylaxis against lipopolysaccharide-induced lung injuries by liposome-entrapped dexamethasone in rats. 2000 Biochem. Pharmacol. pmid:10704946
Rothberg KG and Hitchcock M In vitro biosynthesis of cyclooxygenase metabolites in ovalbumin-sensitized and control lungs of guinea pigs. 1982 Biochem. Pharmacol. pmid:6812589
Joseph S and MacDermot J Stimulation of U937 human monocytic cells by thrombin results in inositol trisphosphate formation and the mobilisation of intracellular Ca2+ but not the synthesis of thromboxane B2. 1991 Biochem. Soc. Trans. pmid:1889682
Bone EA et al. The effects of strontium and calcium ions on 5-hydroxytryptamine secretion and thromboxane B2 biosynthesis in washed human platelets. 1980 Biochem. Soc. Trans. pmid:7450206
Mitchell MD Prostaglandins at parturition and in the neonatal infant. 1980 Biochem. Soc. Trans. pmid:7450282
Taylor L et al. Prostaglandin production by type II alveolar epithelial cells. 1979 Biochim. Biophys. Acta pmid:435506
Chiabrando C et al. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects. 1992 Biochim. Biophys. Acta pmid:1737057
Best LC et al. Lanthanum stimulates the accumulation of cyclic AMP and inhibits secretion and thromboxane B2 formation in human platelets. 1980 Biochim. Biophys. Acta pmid:6251913
Shaw JO et al. Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). 1981 Biochim. Biophys. Acta pmid:7213765
Wahle KW and Peacock LI Effects of isomeric cis and trans eighteen carbon monounsaturated fatty acids on porcine platelet function. 1996 Biochim. Biophys. Acta pmid:8652649
Teng CM et al. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom. 1984 Biochim. Biophys. Acta pmid:6426517
Kimura Y et al. Effects of stilbenes on arachidonate metabolism in leukocytes. 1985 Biochim. Biophys. Acta pmid:3922423
Bellan JA et al. Concentration-activity profile of the modulation of cyclooxygenase product formation by reduced glutathione in microsomal fractions from the goat lung. 1990 Biochim. Biophys. Acta pmid:2114178
Fischer S et al. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites. 1986 Biochim. Biophys. Acta pmid:3754157
Bartolini G et al. Regulation of thromboxane A2 biosynthesis in platelet-free human monocytes and the possible role of polypeptide growth factor(s) in the induction of cyclooxygenase system. 1986 Biochim. Biophys. Acta pmid:3085720
Murota SI et al. Transformation of arachidonic acid into thromboxane B2 by the homogenates of activated macrophages. 1978 Biochim. Biophys. Acta pmid:638172
Aharony D et al. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. 1982 Biochim. Biophys. Acta pmid:6814496
Croft KD et al. Dietary modification of fatty acid and prostaglandin synthesis in the rat. Effect of variations in the level of dietary fat. 1984 Biochim. Biophys. Acta pmid:6548159
Cathcart MC et al. Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer. 2014 Biochim. Biophys. Acta pmid:24480048
Geisel J et al. Endotoxin-induced arachidonic acid metabolism requires de novo protein synthesis and protein kinase C activation. 1991 Biochim. Biophys. Acta pmid:1909897
Maguire MH and Csonka-Khalifah L Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs. 1987 Biochim. Biophys. Acta pmid:3117116
Murota SI et al. The effects of thromboxane B2 and 6-ketoprostaglandin F1alpha on cultured fibroblasts. 1977 Biochim. Biophys. Acta pmid:911847
Patrignani P et al. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. 1989 Biochim. Biophys. Acta pmid:2752041
Ody C et al. 6-Ketoprostaglandin F1 alpha, prostaglandins E2, F2 alpha and thromboxane B2 production by endothelial cells, smooth muscle cells and fibroblasts cultured from piglet aorta. 1982 Biochim. Biophys. Acta pmid:6214281
Wu P et al. Purification and characterization of an NAD(+)-dependent dehydrogenase that catalyzes the oxidation of thromboxane B2 at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B2 radioimmunoassay to enzyme assay. 1990 Biochim. Biophys. Acta pmid:2223826
Malemud CJ et al. Prostaglandin biosynthesis by lapine articular chondrocytes in culture. 1981 Biochim. Biophys. Acta pmid:6894251
Bishai I and Coceani F Transformations of prostaglandin H2 in the cat brain. 1981 Biochim. Biophys. Acta pmid:6894549
Orlandi M et al. Thromboxane A2 synthase activity in platelet free human monocytes. 1994 Biochim. Biophys. Acta pmid:7811713
Truitt A et al. Antiplatelet effects of conjugated linoleic acid isomers. 1999 Biochim. Biophys. Acta pmid:10320806
Huang TF et al. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom. 1987 Biochim. Biophys. Acta pmid:3620499
Sato T et al. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process. 1987 Biochim. Biophys. Acta pmid:3663714
Gorman RR et al. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction. 1979 Biochim. Biophys. Acta pmid:216409
Fitzpatrick FA and Gorman RR Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function. 1979 Biochim. Biophys. Acta pmid:216415
VanRollins M et al. Metabolism of 7,10,13,16-docosatetraenoic acid to dihomo-thromboxane, 14-hydroxy-7,10,12-nonadecatrienoic acid and hydroxy fatty acids by human platelets. 1985 Biochim. Biophys. Acta pmid:3918572
Al-Madaney MM et al. Effects of lipid-esterified conjugated linoleic acid isomers on platelet function: evidence for stimulation of platelet phospholipase activity. 2003 Biochim. Biophys. Acta pmid:14729070
Fuse I and Tai HH Does protein kinase C activation mediate thrombin-induced arachidonate release in human platelets? 1988 Biochim. Biophys. Acta pmid:3140902
Yamaguchi A et al. Secondary signals mediated by GPIIb/IIIa in thrombin-activated platelets. 1990 Biochim. Biophys. Acta pmid:2116909
Asbóth G et al. The relation between thromboxane and prostaglandin synthesis in human decidua tissue: a comparison of eicosanoid synthesis in minced tissue with that in a cell-free preparation. 1989 Biochim. Biophys. Acta pmid:2493805
Coffee KA et al. Altered responses to modulators of guanine nucleotide binding protein activity in endotoxin tolerance. 1990 Biochim. Biophys. Acta pmid:2118385
Mayeux PR et al. Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery. 1989 Biochim. Biophys. Acta pmid:2493809
Huang TF et al. Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib. 1993 Biochim. Biophys. Acta pmid:8251530
Robinson C and Hoult JR Thromboxane A2 analogues inhibit the metabolism of thromboxane B2 in perfused guinea-pig lung. 1983 Biochim. Biophys. Acta pmid:6652102
Bottje W et al. Indomethacin attenuation of hepatic perfusion and plasma 6-ketoPGF1 alpha elevations following glutathione depletion in rabbits. 1991 Biochim. Biophys. Acta pmid:1991131
Croft KD et al. Onset of changes in phospholipid fatty acid composition and prostaglandin synthesis following dietary manipulation with n-6 and n-3 fatty acids in the rat. 1985 Biochim. Biophys. Acta pmid:3995069
Tsunomori M et al. 15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. 1996 Biochim. Biophys. Acta pmid:8679681
Hettasch JM and Le Breton GC Modulation of Ca2+ fluxes in isolated platelet vesicles: effects of cAMP-dependent protein kinase and protein kinase inhibitor on Ca2+ sequestration and release. 1987 Biochim. Biophys. Acta pmid:2820511
Mobley A et al. Selective inhibition of 5-lipoxygenase pathway in rat pulmonary alveolar macrophages by cigarette smoking. 1987 Biochim. Biophys. Acta pmid:3030439
Horton AA and Wood JM Prevention of thromboxane B2-induced hepatocyte plasma membrane bleb formation by certain prostaglandins and a proteinase inhibitor. 1990 Biochim. Biophys. Acta pmid:2107870
Miller OV et al. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence. 1982 Biochim. Biophys. Acta pmid:6285985
Kimura Y et al. Effects of stilbene derivatives on arachidonate metabolism in leukocytes. 1985 Biochim. Biophys. Acta pmid:3931689
Teng CM et al. Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng. 1989 Biochim. Biophys. Acta pmid:2923911
Croft KD et al. Differential inhibition of thromboxane B2 and leukotriene B4 biosynthesis by two naturally occurring acetylenic fatty acids. 1987 Biochim. Biophys. Acta pmid:2822134
Nichols FC et al. Prostaglandin E2, prostaglandin E1 and thromboxane B2 release from human monocytes treated with C3b or bacterial lipopolysaccharide. 1987 Biochim. Biophys. Acta pmid:3101743
Elliott GR et al. Changes in resident rat peritoneal macrophage eicosanoid release, induced by altering the buffer K+/Na+ ratio, are Ca2+ dependent. 1985 Biochim. Biophys. Acta pmid:3933563
Wu CC et al. Antiplatelet effects of clausine-D isolated from Clausena excavata. 1994 Biochim. Biophys. Acta pmid:7918571
Turk J et al. Arachidonic acid metabolism in isolated pancreatic islets. I. Identification and quantitation of lipoxygenase and cyclooxygenase products. 1984 Biochim. Biophys. Acta pmid:6329307
Oglesby TD and Gorman RR The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor. 1984 Biochim. Biophys. Acta pmid:6424715
Ciabattoni G et al. Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. 1987 Biochim. Biophys. Acta pmid:3567215
Barrow SE et al. Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. 1989 Biochim. Biophys. Acta pmid:2679889
Robinson C et al. Thromboxane B2 uptake and metabolism in isolated perfused lung. Identification and comparison with prostaglandin F2 alpha. 1982 Biochim. Biophys. Acta pmid:6751406
Schafer AI et al. Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets. 1982 Biochim. Biophys. Acta pmid:6812645